163 related articles for article (PubMed ID: 25863229)
1. Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers.
Vasconcelos MG; Vasconcelos RG; Pereira de Oliveira DH; de Moura Santos E; Pinto LP; da Silveira ÉJ; Queiroz LM
J Oral Maxillofac Surg; 2015 Sep; 73(9):1753-60. PubMed ID: 25863229
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
4. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
7. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma.
Huang C; Sun Z; Sun Y; Chen X; Zhu X; Fan C; Liu B; Zhao Y; Zhang W
Histopathology; 2012 Apr; 60(5):793-803. PubMed ID: 22320715
[TBL] [Abstract][Full Text] [Related]
8. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
9. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
[TBL] [Abstract][Full Text] [Related]
10. Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation.
Costa AF; Tasso MG; Mariano FV; Soares AB; Chone CT; Crespo AN; Fresno MF; Llorente JL; Suárez C; de Araújo VC; Hermsen M; Altemani A
Histopathology; 2012 Apr; 60(5):816-25. PubMed ID: 22320429
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
12. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma.
Ogane N; Yasuda M; Shimizu M; Miyazawa M; Kamoshida S; Ueda A; Takata K; Sakuma Y; Miyagi Y; Kameda Y
Ann Diagn Pathol; 2010 Feb; 14(1):23-9. PubMed ID: 20123453
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
15. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
16. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM
Cancer Res; 2000 Nov; 60(21):6189-95. PubMed ID: 11085544
[TBL] [Abstract][Full Text] [Related]
17. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Sulkowski S
Pathol Oncol Res; 2007; 13(1):15-20. PubMed ID: 17387384
[TBL] [Abstract][Full Text] [Related]
19. Effect of HIF-1α on biological activation of human tongue squamous cell carcinoma SCC-15 cells in vitro.
Zhou X; Huang D; Xue Z; Xu X; Wang K; Sun Y; Kang F
Int J Oncol; 2015; 46(6):2346-54. PubMed ID: 25816356
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
Li DW; Zhou L; Jin B; Xie J; Dong P
Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
